ASCO® 2024 Insights: "PROs of the MEDISARC Study (AIO-STS-0415) - Durvalumab & Tremelimumab vs. Doxorubicin in Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "PROs of the MEDISARC Study (AIO-STS-0415) - Durvalumab & Tremelimumab vs. Doxorubicin in Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Viktor Grünwald

73 views

June 12, 2024

Comments 1

Treatment Approach for Advanced Gastrointestinal Stromal Tumor (GIST…

Feat. K. Polson

Patient Case Discussion on a Treatment Approach for Advanced Gastroi…

Feat. M. Agulnik

2024 ASCO® Annual Meeting Insights Hub: Sarcoma Videos

ASCO® 2024 Highlights: Advances in GIST Tumors and Soft Tissue Sarco…

2024 ASCO® Annual Meeting Insights Hub

A. Hussein

158 views

3 months ago

ASCO® 2024 Insights: "Efficacy of Nirogacestat in Patients With Poor…

2024 ASCO® Annual Meeting Insights Hub

B. Vincenzi

38 views

3 months ago

ASCO® 2024 Highlights in Sarcomas

2024 ASCO® Annual Meeting Insights Hub

R. Jones

219 views

4 months ago

View All

2024 Update in Sarcomas

Total Health

D. Portnoy

544 views

8 months ago

Developmental Therapeutics Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

533 views

4 months ago

ESMO 2024 Summary: Highlights of Important Trials in Sarcoma

2024 ESMO Annual Meeting Insights Hub

R. Jones

179 views

1 month ago

Sarcoma 101: Multidisciplinary Approach, Therapies, and Future Direc…

Total Health

B. Wilky

226 views

4 months ago

ASCO® 2024 Highlights in Sarcomas

2024 ASCO® Annual Meeting Insights Hub

R. Jones

219 views

4 months ago

NCCN Clinical Practice Guidelines for Treating GIST

Andrea Napolitano

402 views

7 months ago

Gastrointestinal Stromal Tumors (GIST) and Resistance Mutations

Warren Chow

351 views

8 months ago

ASCO® 2024 Highlights: Advances in GIST Tumors and Soft Tissue Sarco…

2024 ASCO® Annual Meeting Insights Hub

A. Hussein

158 views

3 months ago

Systemic Therapies for Uterine Leiomyosarcoma

OncoAlert

I. Ray-Coquard

334 views

9 months ago

What Is New in Treatment of Soft Tissue and Bone Sarcoma

ISCO - International School of Clinical Oncology

S. Stacchiotti

221 views

9 months ago

Divide and Conquer Sarcomas Through Precision Oncology

Miami Cancer Institute Precision Oncology Symposium

N. Somaiah

106 views

5 months ago

Multidisciplinary Management of Advanced Soft Tissue Sarcoma

i3 Health

S. Patel, B. Ruben, K. Polson

250 views

1 year ago

ESMO 2023 Insights: "Novel Combinations in Sarcomas"

Insights from 2023 ESMO Annual Meeting

R. Jones

246 views

1 year ago

Precision Oncology in the Diagnosis and Management of Sarcoma

University of Miami Sylvester Comprehensive Cancer Center

S. Bialick

75 views

3 months ago

INSIGHT: A Phase 3 Study of Ripretinib vs. Sunitinib in Pts With Adv…

Insights from 2024 ASCO® GI Annual Meeting

J. Zalcberg

186 views

8 months ago

ctDNA Analysis From INTRIGUE Study: Updated OS & Safety With Ripreti…

Insights from 2024 ESMO Sarcoma and Rare Cancers Congress

J. Blay

192 views

7 months ago

Sarcoma Panel Discussion: Molecular Tumor Board - Multidisciplinary …

University of Miami Sylvester Comprehensive Cancer Center

P. Seo, A. Rosenberg, P. Castillo, M. De La Fuente, S. Gultekin, E. Krill-Jackson, C. Gomez

79 views

3 months ago

2023 West Oncology Conference: Soft Tissue Sarcoma Updates

2023 West Oncology Conference

B. Van Tine

514 views

1 year ago

Final Analyses From INTRIGUE: OS & Long-Term Safety With Ripretinib …

Insights from 2024 ASCO® GI Annual Meeting

J. Zalcberg

178 views

8 months ago

Fred Hutchinson Cancer Center Sarcoma Updates

Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

M. Wagner

628 views

1 year ago

AUTOPLAY

Login

Login

Join VuMedi

ASCO® 2024 Insights: "PROs of the MEDISARC Study (AIO-STS-0415) - Durvalumab & Tremelimumab vs. Doxorubicin in Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma"

Treatment Approach for Advanced Gastrointestinal Stromal Tumor (GIST…

Patient Case Discussion on a Treatment Approach for Advanced Gastroi…

2024 ASCO® Annual Meeting Insights Hub: Sarcoma Videos

ASCO® 2024 Highlights: Advances in GIST Tumors and Soft Tissue Sarco…

ASCO® 2024 Insights: "Efficacy of Nirogacestat in Patients With Poor…

ASCO® 2024 Highlights in Sarcomas

Recommended

2024 Update in Sarcomas

Developmental Therapeutics Highlights From ASCO® 2024

ESMO 2024 Summary: Highlights of Important Trials in Sarcoma

Sarcoma 101: Multidisciplinary Approach, Therapies, and Future Direc…

ASCO® 2024 Highlights in Sarcomas

NCCN Clinical Practice Guidelines for Treating GIST

Gastrointestinal Stromal Tumors (GIST) and Resistance Mutations

ASCO® 2024 Highlights: Advances in GIST Tumors and Soft Tissue Sarco…

Systemic Therapies for Uterine Leiomyosarcoma

What Is New in Treatment of Soft Tissue and Bone Sarcoma

Divide and Conquer Sarcomas Through Precision Oncology

Multidisciplinary Management of Advanced Soft Tissue Sarcoma

ESMO 2023 Insights: "Novel Combinations in Sarcomas"

Precision Oncology in the Diagnosis and Management of Sarcoma

INSIGHT: A Phase 3 Study of Ripretinib vs. Sunitinib in Pts With Adv…

ctDNA Analysis From INTRIGUE Study: Updated OS & Safety With Ripreti…

Sarcoma Panel Discussion: Molecular Tumor Board - Multidisciplinary …

2023 West Oncology Conference: Soft Tissue Sarcoma Updates

Final Analyses From INTRIGUE: OS & Long-Term Safety With Ripretinib …

Fred Hutchinson Cancer Center Sarcoma Updates